US Patent Issued to KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY on June 23 for "Fusion protein comprising BP26 and antigenic polypeptide" (South Korean Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,662,515, issued on June 23, was assigned to KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (Daejeon, South Korea).

"Fusion protein comprising BP26 and antigenic polypeptide" was invented by Sangyong Jon (Daejeon, South Korea), Sukmo Kang (Chungcheongbuk-do, South Korea), Yujin Kim (Daejeon, South Korea) and Ji-Joon Song (Daejeon, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a fusion protein comprising BP26 and an antigenic polypeptide, and to a nanoarchitecture comprising same. A vaccine composition comprising the fusion protein, nanoarchitecture, or combination thereof of the present disclosure can be...